US SEC Filing Intelligence

Federal Construction & Infrastructure Contracts — October 17, 2026

This digest covers 2 federal construction and infrastructure awards totaling $61,912,177 in obligations, both civilian and both from the General Services Administration Public Buildings Service, with zero defense-related records. Murnane Building Contractors, Inc. received the larger award at $32,914,661 for the Trout River LPOE project (firm fixed price, full and open competition, current end 2028-05-30), but outlays are reported at $0, so its value rests on backlog visibility rather than realized revenue. BURCHICK CONSTRUCTION CO INC holds a $28,997,516 firm fixed price GSA repair and alteration contract in Clarksburg, WV, with $16,435,675 already outlayed (about 57%) and $8,612,364 in subawards. Both awards carry neutral signal strength (3/10) and materiality (3/10), and neither recipient's public listing status is established in the data, which limits direct investment actionability. The highest-conviction observation is steady GSA facilities spending through fixed-price building contracts, while the key watch item is Murnane's outlay progression, since no payments have yet been recorded against its obligation.

DHS Homeland Security Contracts — October 17, 2026

Three DHS awards totaling $173,150,877 in obligations were reviewed, with zero defense-related contracts; all three are civilian homeland security awards to security services and niche services contractors. The dominant theme is DHS spending on detention transport, facility protection, and CBP maintenance support, with GardaWorld Federal Services LLC ($100,467,801 obligated against a $382,324,910 base-plus-options ceiling) carrying the highest materiality. The highest-conviction signal is the scale of unexercised option value in the GardaWorld and Triple Canopy Inc awards, which makes future option exercise the primary driver of revenue visibility. The key watch item is that GardaWorld's $0 outlayed status as of award means no revenue has yet been recognized, so execution and option exercise must be confirmed before the backlog is treated as earnings. None of the three recipients is a listed equity identified in the data, limiting direct public-market relevance.

3 total filings

VA Healthcare & Services Contracts — October 17, 2026

This digest covers two Department of Veterans Affairs awards totaling $67,587,736 in obligations, with zero defense-related contracts, so the entire stream is civilian. The dominant theme is VA facility and IT spending, with BLUEWAY ONE JV LLC's $48,924,250 firm-fixed-price boiler replacement at the Albany VAMC (through 2028-02-23) accounting for roughly 72% of the total value and KING STREET TECHNOLOGY PARTNERS, LLC's $18,663,485 Enterprise Mobility Management delivery order (through 2027-05-01) making up the rest. The highest-conviction read is the durable, fixed-price nature of the BLUEWAY award and its small-business/SDVOSB set-aside structure, but neither recipient is established as publicly traded, so direct equity implications are unconfirmed. The key watch item is the unresolved discrepancy in the KING STREET award between its SDVOSB set-aside designation and its listed full-and-open competition type, alongside BLUEWAY's $0 outlayed to date.

HHS & Healthcare Contracts Intelligence — October 17, 2026

This digest covers a single HHS contract record totaling $91,580,433 in obligations, all civilian and none defense-related. The dominant theme is continued NIH/NIAID funding for infectious disease research infrastructure, awarded to American Type Culture Collection (Manassas, VA). The highest-conviction read is the cost-plus-fixed-fee structure, which shifts cost-overrun risk to the government and implies lower margin volatility. The primary watch item is option exercise: the $91,580,433 obligated represents only a fraction of the $334,258,869 base-plus-options value, so most potential value depends on future option decisions. The recipient is a nonprofit with no public-equity data in the source, so direct stock-level investment read-through is limited; the signal is best treated as a durable research-services award rather than an equity catalyst.

New Federal Contractors — October 17, 2026

The 16 new federal contract awards in this period total $608,570,459 in obligations, with zero defense-related awards and all 16 classified as civilian (DHS, HHS/NIH, DOL, VA, GSA, USDA Forest Service, NASA). The dominant themes are homeland security and federal facilities/services work, led by GardaWorld Federal Services LLC's $100,467,801 DHS/ICE transportation award and Triple Canopy Inc's $47,581,167 DHS Federal Protective Service delivery order. Every signal in the set is rated neutral, with an average signal strength of 3.0/10, reflecting that most awards are single, private, or non-public recipients with limited direct equity read-through. The highest-conviction item is the DHS/ICE GardaWorld award, though only about 26% of its $382,324,910 ceiling is currently obligated and its $0 outlay leaves revenue unproven. The key watch item is option exercise: across the large awards, the gap between obligated value and base-plus-options ceilings (for example, roughly $282M unobligated on GardaWorld and $48.9M-equivalent gaps elsewhere) means realized backlog depends on future funding actions.

Significant Contract Modifications ($10M+) — October 17, 2026

The 16 significant contract modifications in the October 17, 2026 snapshot total $608,570,459 in obligations, with zero defense-related awards and the entire stream sitting in civilian agencies: DHS, HHS/NIH, DOL, VA, USDA Forest Service, GSA, NASA. The dominant themes are homeland security guard and transportation services, Job Corps operations, facility construction and repair, and wildfire airtanker services. The highest-materiality award is GardaWorld Federal Services' $100,467,801 DHS/ICE 287(g) transport contract, though only about 26% of its $382,324,910 ceiling is currently obligated and total outlays stand at $0. Every contract in the stream is rated neutral (average signal strength 3.0/10), so the digest carries no bullish or bearish directional call; the key watch item is option exercise and first outlays across the largest awards, especially GardaWorld, which carries high pricing risk on a firm fixed-price structure.

Contract Deobligations Alert — October 17, 2026

The 16 contracts in this October 17, 2026 deobligations-alert stream total $608,570,459 in aggregate obligations, with zero defense-related awards and all 16 awards classified as civilian (DHS, HHS, DOL, VA, GSA, USDA, NASA). The dominant themes are DHS and DOL/Job Corps-style services, facilities and construction work at GSA and VA, and wildfire airtanker aviation at USDA Forest Service. The highest-materiality signal is GardaWorld Federal Services LLC's $100,467,801 DHS/ICE detention transportation award, though only about 26% of its $382,324,910 ceiling is obligated and it carries high pricing risk on a firm fixed-price structure. Most recipients are private, nonprofit, or unidentified as to public listing, which limits direct equity read-through across the stream. The key watch item is the large unobligated option value (GardaWorld, Triple Canopy, Coulson Aviation, AERO AIR) and whether options are exercised, given that several awards show $0 or very low outlays and the stream is an alert of deobligations-related activity.

Contract Option Exercises — October 17, 2026

Sixteen federal contract option-exercise records totaling $608,570,459 in obligations were reviewed for the single-day period of October 17, 2026, with zero defense-related awards, so the entire batch is civilian (DHS, HHS/NIH, DOL, VA, USDA Forest Service, GSA, NASA). The dominant themes are homeland security and protective services (GardaWorld $100.5M and Triple Canopy $47.6M), Job Corps operations (Management & Training Corp and ARBOR E&T), and federal facilities construction and repair (Murnane, Burchick, BLUEWAY ONE). The highest-materiality award is GardaWorld Federal Services' $100,467,801 DHS/ICE transportation contract, but only about 26% of its $382.3M ceiling is currently obligated and total outlays are $0, so conviction is low until options are exercised. Average signal strength is 3.0/10 and all 16 records are rated neutral; several awards carry stale period-of-performance dates (e.g., Management & Training Corp's 2022 end date, University of Dayton's 2024 end date), which reduces their current relevance. The key watch item is option exercise and first outlay progression on the large DHS and VA awards, since most of the reported value remains contingent.

Federal Professional Services Contracts — October 17, 2026

This digest covers a single federal professional services contract totaling $18,424,820, awarded by the General Services Administration (FAS AAS Region 5) to the University of Dayton on 2022-07-13 for 'Automation and Robotics' engineering support. The award is entirely civilian (0 of 1 records defense-related), and the dominant theme is modest civilian demand for automation and robotics engineering services rather than a defense-driven catalyst. The highest-conviction observation is that the award is neutral in signal strength (2/10) and the recipient is a nonprofit higher education institution, so it carries no direct public-equity exposure. The key watch item is the extremely low burn rate: only $16,925 has been outlaid against the full $18,424,820 obligation, with the performance period ending 2024-10-14, which raises questions about execution and whether the period has already lapsed relative to the data snapshot. Aggregate average signal strength is 2.0/10, reflecting limited investable information in this stream.

Federal IT & Cybersecurity Contracts — October 17, 2026

Two federal IT and cybersecurity awards totaling $32,778,981 in total obligation were analyzed for the period October 17, 2026, with zero defense-related contracts, so the entire digest reflects civilian agency spending. The dominant themes are civilian IT modernization at the Department of Veterans Affairs ($18,663,485 to King Street Technology Partners, LLC) and the General Services Administration ($14,115,496 to General Dynamics Information Technology, Inc.), both focused on enterprise application and mobility services. The highest-conviction read is that civilian enterprise software and services demand remains active, though neither award is material to a diversified portfolio and King Street is privately held. Both signals are rated neutral (strength 2/10 and 3/10), so no contract warrants a bullish or bearish call on its own. The key watch item is an apparent inconsistency in the VA award, which is coded as a service-disabled veteran-owned small business set-aside yet listed as full and open competition, and which should be verified before drawing any conclusion from it.

NASA & Space Contracts Intelligence — October 17, 2026

This digest covers a single NASA & Space contract record totaling $17,137,851 in obligations, with zero defense-related awards and a civilian-only split of 100%. The dominant theme is sustained NASA applied-research funding flowing through the JPL management office to California Institute of Technology, a nonprofit higher-education recipient with no identified publicly traded parent. The highest-conviction read is durability: a 10-year cost-plus-fixed-fee delivery order (2018-10-01 to 2028-09-30) with a $21,669,510 base-plus-options ceiling and $11,042,681 already outlayed (roughly 51% of the obligation). The average signal strength is 3.0/10 and materiality is 2/10, so this award carries minimal direct equity investment relevance. The key watch item is option exercise and any modification lifting the obligation toward the $21,669,510 ceiling, alongside NASA JPL budget changes that could affect outlay pacing.

All HHS Contracts — October 17, 2026

This digest covers a single HHS contract record dated October 17, 2026 within the All HHS Contracts stream, totaling $91,580,433 in obligation with zero defense-related awards and an average signal strength of 3.0/10. The sole award is a cost-plus-fixed-fee definitive contract from NIH/NIAID to American Type Culture Collection (Manassas, VA) under the Biological and Emerging Infections Research Resources Program (BEI-RRP), with a base-plus-options value of $334,258,869 and $57,345,176 outlayed to date. The dominant theme is civilian life-sciences research infrastructure funding within HHS, with no defense exposure. The highest-conviction read is durable government research-services demand, though the recipient is a nonprofit with no identified public-equity link, so direct investment catalyst value is limited. The key watch item is option exercise, since roughly $242.7 million of the $334.3 million potential value (about 73%) remains contingent on future option decisions not yet guaranteed.

Mega Contracts Monitor ($100M+) — October 17, 2026

This digest covers a single mega contract ($100M+ stream) with a total obligation of $100,467,801 awarded on 2026-08-31 for the period of October 17, 2026, with zero defense-related awards (0/1), so the entire signal set is civilian. The dominant theme is DHS/ICE detention and removal logistics, specifically GardaWorld Federal Services LLC's firm fixed-price contract for 24/7/365 armed ground transportation under the 287(g) program in Texas. The highest-conviction signal is the contractor's backlog addition, though it is modest in conviction because only about 26% of the $382,324,910 base-plus-options ceiling is currently obligated, leaving most value contingent on option exercises. The key risk is execution: total outlays were reported as $0 at award, and the firm fixed-price structure places cost-overrun exposure squarely on the contractor. Average signal strength was 4.0/10, and the single signal is neutral.

High-Value Federal Grants ($5M+) — October 17, 2026

The 16 high-value federal awards in this period (2026-10-17) carry a combined $608,570,459 in total obligation, yet none are defense-related (0/16); the entire stream is civilian, led by DHS, HHS, DOL, VA, GSA, USDA and NASA. The dominant themes are security and guard services (GardaWorld Federal Services LLC at $100,467,801 and Triple Canopy Inc at $47,581,167), Job Corps operations, and facilities/construction work. The highest-conviction item is GardaWorld's $100,467,801 DHS/ICE award, but only about 26% of its $382,324,910 base-plus-options ceiling is obligated, so value depends on option exercise. Key watch item: none of the recipients is shown to be publicly traded in the data, so direct equity read-through is limited, and total outlays are $0 on several of the largest new awards.

General Federal Contracts — October 17, 2026

Across 16 federal contracts totaling $608,570,459 in obligations, none are defense-related; the entire set is civilian, spanning DHS (ICE/CBP/FPS), HHS/NIH, DOL Job Corps, VA, USDA Forest Service, GSA, and NASA. The largest and highest-materiality award is GardaWorld Federal Services' $100,467,801 DHS/ICE detention transportation contract, though only about 26% of its $382,324,910 ceiling is obligated and no outlays are recorded. Themes cluster around federal security and detention services, facilities and construction under GSA/VA, and wildfire aviation under USDA. The highest-conviction signal is the Forest Service airtanker work for Coulson Aviation (USA) ($27,996,631, 82% outlayed with roughly $20.0M of unobligated option value), which indicates durable multi-year revenue visibility. The key watch item is option exercise on large partially obligated awards, most notably GardaWorld and Triple Canopy, where unexercised option value is a meaningful share of potential revenue; several recipients are privately held or nonprofit, limiting direct equity implications.

All NASA Contracts — October 17, 2026

This digest covers two NASA contracts totaling $32,668,591 in obligations, both civilian and neither defense-related (0 of 2). The dominant theme is sustained NASA civilian spending routed through the Jet Propulsion Laboratory management office and the Marshall Space Flight Center logistics vehicle, but neither award maps to a publicly traded parent in the provided data. Both signals are rated neutral with average strength of 3.0/10 and materiality of 2/10, so no bullish or bearish conviction is warranted. The highest-weight item is California Institute of Technology's $17,137,851 cost-plus-fixed-fee delivery order (about 51% outlayed), which signals durable NASA R&D funding but offers no direct equity exposure. The key watch item is Akima Global Logistics' $15,530,739 MSFC award, where high pricing risk and only about 34% outlay progress warrant monitoring of option exercises toward the $18,300,000 ceiling.

October 16, 2026 · daily

Biotech Small-Cap Approvals — October 16, 2026

This digest covers a single-day-window stream of three FDA actions dated October 9 to 13, 2026, with no NMEs classified by mix (0 NME, 0 biosimilar, 0 label expansion in the mix tally) and three 'Other' designations; however, the individual analyses identify PRITELIVIR (AiCuris Anti-Infective Cures AG) as an NME approval under Priority Review, making it the highest-conviction event in the set. Pritelivir, branded HOVILPR, carries an 8/10 signal strength and materiality, and its Priority Review designation signals FDA recognition of significant unmet need in its indication. The remaining two actions are a biosimilar-designated approval of donepezil hydrochloride from Strides Pharma International (neutral, 5/10) and a label expansion for iopamidol (ISOVUE READI) from Bracco (bullish, 5/10). No dominant therapeutic area cluster is evident from the available data, as the three approvals span antiviral, neurology, and contrast imaging categories. The key watch item is the classification inconsistency: the Donepezil entry is labeled biosimilar in its summary yet the approval type is recorded as FALLBACK, and commercial metrics across all three entries are NOT_DISCLOSED, limiting quantitative conviction.

3 total filings

October 16, 2026 · daily

NME Blockbuster Approvals — October 16, 2026

This digest covers a single FDA approval event in the October 16, 2026 reporting window, which is the sole entry in the NME Blockbuster Approvals stream. The approval mix is 0 NMEs, 0 biosimilars, 0 label expansions, and 1 other action, so no first-in-class molecular entity or biosimilar entrant is captured in this period. The one event is PRITELIVIR (HOVILPR), approved for AICURIS Anti-Infective Cures AG under a Priority Review designation, which the source classifies as an NME approval with a fallback approval-type tag. The highest-conviction signal is bullish (strength 8/10, materiality 8/10) for AICURIS, given that Priority Review status signals FDA recognition of significant benefit, though peak sales, exclusivity period, pricing power, and market position are all NOT_DISCLOSED and cannot be quantified from available data. No therapeutic area clustering is observable from a single approval. The key watch item is the classification ambiguity (NME label versus fallback approval type), which should be verified against the FDA action letter before the position is sized, along with the absence of any disclosed commercial parameters.